Influence 3-formylchromone derivatives in vitro at aggregation of p-amyloid plagues and tyrosinase activity


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objectives. Alzheimer's disease is one of the most common terminal forms of dementia, characterized by a complex pathogenesis with the formation of amyloid plagues in the brain structures. At the same time, one of the new and promising areas of Alzheimer's disease therapy is the influence on the amyloidogenic cascade. Aim of the study. In vitro to evaluate the effect of ten 3-formylchromone derivatives on the formation of p-amyloid aggregates and tyrosinase activity. Materials and methods. The effect of the studied compounds on tyrosinase activity was evaluated using the Mapunyamethod, using L-tyrosine as a substrate and kojic acid as a reference. Aggregation of amyloid plagueswas studied spectrophotometrically in reaction with Congo red after three and six days of incubation. Results. Among the test-objects, the most significant antithyrosinase properties were found in the 6-acetyl substituted derivative of 3-formylchromone, whose IC50 value was comparable to kojic acid (32±1.913 pg/ml versus 30.2±1.599 pg/ml). Also, this compound most significantly inhibited the aggregation of amyloid plagues on the third day of incubation-31.0% (p<0.05) and 61% (p<0.05) - on the sixth day. It should be noted that 3-formylchromone and oxime of this compound had no significant effect on tyrosinase activity and amyloidogenesis. Conclusion. This study suggests the relevance of further study of 6-acetyl-substituted 3-formylchronome as a potential means of pathogenetic therapy of Alzheimer's disease.

Full Text

Restricted Access

About the authors

D. I Pozdnyakov

Pyatigorsk Medical-Pharmaceutical Institute

Email: pozdniackow.dmitry@yandex.ru
Ph.D. (Pharm.), Head of Living System Laboratory, Associate Professor, Department of Pharmacology with Clinical Pharmacology Course

V. M Rukovitsyna

Pyatigorsk Medical-Pharmaceutical Institute

Email: rukovicina.vika@mail.ru
Post-graduate Student, Department of Organic Chemistry

M. V Larskij

Pyatigorsk Medical-Pharmaceutical Institute

Email: pharmachemistry@mail.ru
Ph.D. (Pharm.), Head of Pharmaceutical Chemistry Department

References

  1. Takizawa C., Thompson P.L., van Walsem A, et al. Epidemiological and economic burden of Alzheimer's disease: a systematic literature review of data across Europe and the United States of America. J Alzheimers Dis. 2015; 43(4): 1271-84. 10.3233/JAD-141134
  2. Prince M, Wimo A.,Guerchet M., Gemma Claire Ali, Yu-Tzu Wu, Matthew A. Prim. World Alzheimer Report 2015. The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. 2015.
  3. Kerr J.S., Adriaanse B.A., Greig N.H. et al. Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms. Trends Neurosci. 2017;40(3): 151-166. doi: 10.1016/j.tins.2017.01.002
  4. Mattson M.P. Pathways towards and away from Alzheimer’s disease. Nature. 2004; 430(7000):631-639.
  5. Wang R., Tang P., Wang P., Boissy R.E., Zheng H. Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation. Proc Natl. Acad. Sci. USA. 2006; 103(2):-353-358. doi: 10.1073/pnas.0509822102
  6. Arbor S.C., La Fontaine M., Cumbay M. Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores. Yale J. Biol. Med. 2016; 89(1):5-21.
  7. Mapunya M.B., Nikolova R.V., Lall N. Melanogenesis and antityrosinase activity of selected South african plants. Evid. Based Complement Alternat. Med. 2012; 2012: 374017. doi: 10.1155/2012/374017
  8. Wang W., Zhao C., Zhu D., Gong G., Du W. Inhibition of amyloid peptide fibril formation by gold-sulfur complexes. J Inorg. Biochem. 2017; 171:1-9. doi: 10.1016/jjinorgbio.2017.02.021
  9. Esquerda-Canals G., Montoliu-Gaya L.,Guell-Bosch J., Villegas S. Mouse Models of Alzheimer's Disease. J. Alzheimersw Dis. 2017; 57(4):1171-1183. doi: 10.3233/JAD-170045
  10. De Biase D., Costagliola A., Pagano T.B., et al. Amyloid precursor protein, lipofuscin accumulation and expression of autophagy markers in aged bovine brain. BMC Vet. Res. 2017; 13(1): 102. doi: 10.1186/s12917-017-1028-1
  11. Ohm T.G., Braak H. The pigmented subpeduncular nucleus: a neuromelanin-containing nucleus in the human pontine tegmentum. Morphology and changes in Alzheimer's disease. Acta Neuropathol. 1988; 77(1):26-32. doi: 10.1007/BF00688239

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies